packageLinagliptin

linagliptin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Linagliptin is a DPP-4 inhibitor used to lower blood sugar in adults with type 2 diabetes, available alone or in fixed oral combinations with other glucose-lowering drugs. It is approved and authorised in the European Union and is widely used as an oral anti-diabetic medicine.

Summary written by glm-5.3-flash from Wikidata Q909745 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:linagliptin
ATC codes:A10BH05
DrugBank:DB08882
PubChem CID:10096344
ChEBI:68610
Wikidata:Q909745
formula:C25H28N8O2
molar mass:472.553 g/mol (PubChem CID 10096344)
logP:1.9 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown